26 Nov 2019 07:00
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (596/2014/EU) ("MAR").
November 26, 2019
Verseon Corporation
("Verseon" or the "Company")
Cancellation of Depositary Interests Facility
FREMONT, Calif.-Verseon Corporation (AIM:VERS), a clinical-stage pharmaceutical company, today announces that it will not maintain its depositary interests ("DIs") facility following the intended cancellation of the Company's AIM listing, which, subject to shareholder approval, is expected to take effect on December 19, 2019 (the "Cancellation"). In accordance with the terms of the DI trust deed, the Company has directed its depositary, Computershare Investor Services PLC ("Computershare"), to terminate the DIs with effect from December 30, 2019 (the "Effective Date"). Computershare will give notice of termination to all DI holders.
Tender of Common Shares to the Company
DI holders should note that prior to 1:00 p.m. GMT on December 9, 2019, any DI holder may elect to tender their respective holding of DIs pursuant to the procedures set out in the tender offer circular dated November 22, 2019.
All DIs remaining as at the Effective Date will be cancelled, DI holders will be entered as shareholders on the Company's share register, and share certificates will be issued to the holders of such Common Shares.
- Ends -
For further information, please contact
Verseon Corporation | www.verseon.com |
Sebastian Wykeham / Tina Schlafly | +1 (510) 225 9000 |
Arden Partners (NOMAD and Broker) | |
Ruari McGirr / Ciaran Walsh / Dan Gee-Summons (Corporate Finance) | +44 (0) 20 7614 5900 |